Johnson & Johnson vs UnitedHealth Group Incorporated at a glance
Both companies operate in the Health Care sector, so these figures are broadly like-for-like.
| Metric | JNJ | UNH |
|---|---|---|
| Market cap | $654.04B | $356.01B |
| Price | $268.04 | $392.95 |
| P/E ratio (TTM) | 18.74 | 24.76 |
| P/B ratio (MRQ) | 6.16 | 3.17 |
| P/S ratio (TTM) | 5.33 | 0.67 |
| Revenue growth (1Y) | 6.05% | 11.81% |
| Return on equity (TTM) | 32.87% | 12.81% |
| Return on invested capital (TTM) | 16.26% | 9.58% |
| Gross margin (TTM) | 75.17% | 22.49% |
| Net margin (TTM) | 21.48% | 3.14% |
| Dividend yield (TTM) | 2.00% | 2.36% |
How they differ
Johnson & Johnson is the larger company at $654.04B versus $356.01B — about 1.8x the size.
On trailing earnings, Johnson & Johnson is the cheaper of the two at 18.74 against 24.76 for UnitedHealth Group Incorporated.
On sales, UnitedHealth Group Incorporated is the cheaper of the two at 0.67 against 5.33 for Johnson & Johnson.
UnitedHealth Group Incorporated leads on revenue growth over the past year, 11.81% against 6.05%.
Johnson & Johnson leads on return on invested capital, 16.26% against 9.58%.
Johnson & Johnson leads on gross margin, 75.17% against 22.49%.
UnitedHealth Group Incorporated offers the higher yield at 2.36% against 2.00%.
Go deeper
Ratios describe the past. Whether either is worth owning depends on what you pay today.
Related comparisons
Other matchups involving Johnson & Johnson or UnitedHealth Group Incorporated.